uu.seUppsala universitets publikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Bupivacaine inhibits endothelin-1-evoked increases in intracellular calcium in model sensory neurons
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för farmaceutisk biovetenskap.
2015 (Engelska)Ingår i: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, E-ISSN 1399-6576, Vol. 59, nr 7, s. 936-945Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

BackgroundEndothelin-1 (ET-1) induces pain-like behavior in animals and man by activating the G(q) protein-coupled receptor endothelin-A (ETA). Activation of ETA receptors on nociceptor membranes evokes intracellular calcium transients and alters membrane Na+ and K+ channel and TRPV1 currents, leading to neuronal hyper-excitability manifested by spontaneous and evoked pain behaviors in vivo. In addition to blocking sodium channels, local anesthetics inhibit the G(q) protein-coupled signaling of several inflammatory and pro-algesic mediators. In this study, we aimed to investigate the actions of local anesthetics on ETA-mediated increases in intracellular calcium in ND7/104 model sensory neurons. MethodsIncreases in intracellular calcium were measured by the fluorescent indicator fura-2 in a sensory neuron-derived cell line (ND7/104), which endogenously expresses ETA receptors. Effects of lidocaine and bupivacaine, along with their respective membrane-impermeant derivatives QX-314, LEA-123 and LEA-124, on peak calcium responses to ET-1 were measured. ResultsBupivacaine suppressed ET-1 responses in a concentration-dependent and non-competitive manner with an IC50 of 3.791.63mM. Bupivacaine (6mM) reduced the E-max for ET-1 from 50.07 +/- 1.91mM to 27.30 +/- 2.92mM. The actions of bupivacaine occurred quickly and were rapidly reversible. Membrane-impermeant analogs of bupivacaine (LEA-123 and LEA-124, 6mM) were without effect, as was lidocaine (10mM) and its quaternary derivative QX-314 (10mM). ConclusionBupivacaine inhibits ETA-mediated calcium transients at clinically relevant concentrations through an intracellular target. The anti-inflammatory and analgesic actions of bupivacaine may be at least partially due to its inhibitory action on G(q)-coupled receptors, including ETA.

Ort, förlag, år, upplaga, sidor
2015. Vol. 59, nr 7, s. 936-945
Nationell ämneskategori
Farmaceutiska vetenskaper Anestesi och intensivvård
Identifikatorer
URN: urn:nbn:se:uu:diva-260268DOI: 10.1111/aas.12481ISI: 000357969800013PubMedID: 25684033OAI: oai:DiVA.org:uu-260268DiVA, id: diva2:847866
Tillgänglig från: 2015-08-21 Skapad: 2015-08-18 Senast uppdaterad: 2018-01-11Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMed
Av organisationen
Institutionen för farmaceutisk biovetenskap
I samma tidskrift
Acta Anaesthesiologica Scandinavica
Farmaceutiska vetenskaperAnestesi och intensivvård

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 349 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf